Neuraxis Income Statement (2022-2025) | NRXS

Income Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.68M0.62M0.61M0.81M0.65M0.48M0.53M0.65M0.61M0.67M0.76M0.90M0.89M0.81M
Cost of Revenue 0.13M0.08M0.07M0.11M0.08M0.07M0.07M0.08M0.07M0.34M-0.65M0.14M0.15M0.76M
Gross Profit 0.60M0.55M0.54M0.71M0.58M0.41M0.46M0.57M0.54M0.57M0.66M0.76M0.75M0.68M
Operating items
Research & Development 0.01M0.09M0.08M0.02M0.11M0.04M-0.00M0.01M0.05M0.13M-0.09M0.06M0.06M0.13M
Selling, General & Administrative 1.13M1.59M1.38M1.48M1.51M3.32M2.01M2.32M2.63M1.76M2.90M2.86M2.26M1.88M
Operating Expenses 1.15M1.67M1.46M1.50M1.62M3.37M2.01M2.32M2.68M1.88M2.81M2.92M2.32M2.01M
Operating Income -0.67M-1.20M-0.99M-0.90M-1.12M-3.02M-1.62M-1.83M-2.21M-1.65M-1.47M-2.30M-1.72M-2.10M
EBIT -0.67M-1.20M-0.99M-0.90M-1.12M-3.02M-1.62M-1.83M-2.21M-1.65M-1.47M-2.30M-1.72M-2.10M
Non-operating items
Interest & Investment Income 0.00M
Other Non Operating Income -0.85M-0.88M0.97M-1.28M-1.12M-5.60M0.03M-0.29M-0.71M-0.10M0.02M0.02M0.04M0.04M
Non Operating Income -0.85M-0.88M0.97M-1.28M-1.12M-5.60M0.03M-0.29M-0.71M-0.10M0.02M0.02M0.03M-0.02M
Net income details
EBT -0.70M-1.30M-1.14M-1.06M-1.31M-3.12M-1.65M-1.86M-2.78M-1.72M-0.88M-2.30M-1.73M-2.13M
Profit After Tax -1.52M-2.08M-0.01M-2.17M-2.24M-8.63M-1.59M-2.12M-2.92M-1.76M-1.45M-2.28M-1.69M-2.12M
Income from Continuing Operations -0.70M-1.30M-1.14M-1.06M-1.31M-3.12M-1.65M-1.86M-2.78M-1.72M-0.88M-2.30M-1.73M-2.13M
Consolidated Net Income -0.70M-1.30M-1.14M-1.06M-1.31M-3.12M-1.65M-1.86M-2.78M-1.72M-0.88M-2.30M-1.73M-2.13M
Income towards Parent Company -0.70M-1.30M-1.14M-1.06M-1.31M-3.12M-1.65M-1.86M-2.78M-1.72M-0.88M-2.30M-1.73M-2.13M
Preferred Dividend Payments 0.04M0.17M0.21M0.21M0.20M
Net Income towards Common Stockholders -1.71M-2.27M-0.21M-1.06M-2.43M-4.90M-5.31M-2.12M-2.92M-1.80M-1.61M-2.49M-1.90M-2.32M
Additional items
EPS (Basic) -0.87-1.14-0.10-1.18-1.21-2.380.61-0.32-0.42-0.25-0.23-0.33-0.22-0.24
EPS (Weighted Average and Diluted) -0.87-1.14-0.10-1.18-1.21-2.380.61-0.32-0.42-0.25-0.23-0.33-0.22-0.24
Shares Outstanding (Weighted Average) 1.97M1.99M2.00M2.00M2.00M3.63M3.25M6.55M6.92M7.17M6.92M7.46M8.52M9.88M
Shares Outstanding (Diluted Average) 1.97M1.99M2.00M2.00M2.00M3.63M3.25M6.55M6.92M7.17M6.92M7.46M8.52M9.88M
EBITDA -0.67M-1.20M-0.99M-0.90M-1.12M-3.02M-1.62M-1.83M-2.21M-1.65M-1.47M-2.30M-1.72M-2.10M
Interest Expenses 0.03M0.10M0.16M0.16M0.19M0.10M0.02M0.03M0.58M0.06M-0.58M0.00M0.01M0.03M